Atwood & Palmer’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
BPC
DLA
OIAM
YIH
CNB
COPPSERS
CUAMC
Atwood & Palmer's MRNA Position: Q2 2026 in Review
Atwood & Palmer held its Moderna (MRNA) position steady in Q2 2026 at 100 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #388.
Atwood & Palmer first reported a position in MRNA in Q3 2020 and has held it in 24 quarters since. The position peaked at $327K in Q3 2021. 184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Atwood & Palmer held 100 shares of Moderna worth $7K as of Q2 2026.
- Atwood & Palmer left its Moderna share count unchanged in Q2 2026.
- Moderna made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #388 holding.
- Atwood & Palmer first reported a position in Moderna in Q3 2020 and has held it in 24 quarters since.
- Atwood & Palmer's Moderna position peaked at $327K in Q3 2021.
- 184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.